The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic
Recruiting now · Not applicable
Conditions studied: Asthma in Children, Depression
In brief
The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?
Key facts
- Study ID
- NCT06623981
- Run by
- Children's National Research Institute
- People needed
- 60
- Starts
- 2024-10-15
- Expected to finish
- 2027-03-15
- Last updated by the study team
- 2026-02-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Maternal:
- Primary caregiver of the child with asthma seen at the community-based asthma clinic
- Female (self-identified)
- Black (self-identified)
- ≥ 18 years of age
- English-speaking
- PHQ-9 ≥ 8 during standardized screening at the child with asthma's clinic visit
- Child:
- <18 years old for the duration of the 6-month study period
- Publicly insured
- Physician-diagnosed persistent asthma
You may not qualify if…
- Maternal:
- Acutely suicidal (high risk on the C-SSRS at child's asthma clinic visit)
- Bipolar disorder or mania
- Schizophrenia
- Current substance abuse/dependence
- Current serious physical intimate partner violence (IPV)
- Lack of capacity to meaningfully participate in study procedures, as assessed by study staff during screening
- Child:
- Significant medical co-morbidity (e.g., disorders of the cardiorespiratory system, significant developmental delay, diabetes, seizure disorder, and sickle cell disease)
- Enrolled in another intervention with a behavioral component and/or novel asthma therapeutics
Where it is running
- Children's National Hospital — Washington D.C., District of Columbia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.